National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 5/30/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Jeremy S. Abramson, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.;
Constellation, Inc.;
Gilead;
Seattle Genetics;
Pharmacyclics

Amgen Inc.;
Millennium Pharmaceuticals, Inc.;
Gilead;
Infinity;
Juno

None

None

None

4/28/2015

Ranjana H. Advani, MD

Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Agensys;
Allos Therapeutics;
Idera Pharmaceuticals;
Idera Pharmaceuticals;
Regeneron Pharmaceuticals, Inc.;
Seattle Genetics;
Pharmacyclics

Genentech, Inc.;
Seattle Genetics

None

None

None

5/21/2015

C. Babis Andreadis, MD, MSCE

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
AVEO pharmaceuticals

Bristol-Myers Squibb Company;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

Genentech, Inc.;
Roche Laboratories, Inc.

1/7/2015

Nancy Bartlett, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
MedImmune Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
ImaginAb;
Seattle Genetics;
Pfizer Inc.;
Pharmacyclics

None

Gilead;
Seattle Genetics

None

None

4/14/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

John C. Byrd, MD

None

None

Genentech, Inc.;
Acerta;
Pharmacyclics

None

None

4/24/2015

Myron S. Czuczman, MD

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead

Boehringer Ingelheim GmbH;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Algeta;
Gilead;
MorphoSys;
Mundipharma;
T G Therapeutics;
Teva

None

None

None

5/22/2014

Mary Dwyer, MS

None

None

None

None

None

4/10/2015

Luis E. Fayad, MD

Centocor, Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

None

None

None

None

3/5/2015

Richard I. Fisher, MD

None

Celgene Corporation;
Johnson & Johnson;
MorphoSys AG

None

None

None

12/18/2014

Francine Foss, MD

Celgene Corporation;
LYSA;
Takeda Pharmaceuticals North America, Inc.

Eisai Inc.

Celgene Corporation;
Seattle Genetics

None

None

Pending

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Martha J. Glenn, MD

Amgen Inc.;
sanofi-aventis U.S.

None

None

None

None

5/27/2015

Leo I. Gordon, MD

Jannsen Pharmaceutica Products, LP

None

None

None

None

12/16/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Thomas M. Habermann, MD

None

None

None

None

None

5/3/2015

Nancy Lee Harris, MD

Pharmacyclics

None

None

None

None

1/26/2015

Richard T. Hoppe, MD

None

None

None

None

None

12/15/2014

Steven M. Horwitz, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
;
Infinity;
Kiowa-Kirin;
Seattle Genetics;
spectrum

Amgen Inc.;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Immunogen;
Kiowa Hakka Kirin;
seattle genetics;
Spectrum

None

None

None

4/25/2015

Mark S. Kaminski, MD

GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Wyeth Pharmaceuticals

None

None

None

None

1/8/2015

Christopher R. Kelsey, MD

Varian Medical Systems, Inc.

None

None

None

None

1/30/2015

Youn H. Kim, MD

Eisai Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
KHK;
Seattle Genetics;
Tetralogic

Celgene Corporation;
Eisai Inc.;
Millennium Pharmaceuticals, Inc.;
Actelion;
Galderma;
KHK;
Miragen;
Seattle Genetics

None

None

None

3/4/2015

Susan Krivacic, MPAff

None

None

None

None

None

5/1/2015

Ann S. LaCasce, MD

Seattle Genetics

GlaxoSmithKline

None

None

None

5/1/2015

Matthew Lunning, DO

None

Celgene Corporation;
Genentech, Inc.;
Gilead;
Juno;
Spectrum;
TG therapeutics

None

None

None

2/4/2015

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Auayporn Nademanee, MD

Jannsen Pharmaceutica Products, LP;
Seattle Genetics Co.

gilead

None

None

None

1/7/2015

Elise A. Olsen, MD

Eisai Inc.

Celgene Corporation;
AccreditEd;
Actelion;
Allergan;
Seattle Genetics

None

None

None

5/1/2015

Pierluigi Porcu, MD

Infinity;
OncoMed;
Seattle Genetics

Celgene Corporation;
Actelion;
KIOWA Kirin

Celgene Corporation;
Actelion

None

None

9/19/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

Adaptive Biotechnologies

None

Emergent Biosolutions

None

4/16/2015

Rachel Rabinovitch, MD

RTOG Data Safety and Monitoring Board

Accuray Incorporated

None

None

None

4/14/2015

Nishitha Reddy, MD

Celgene Corporation

Celgene Corporation;
Janssen Pharmaceutica Products;
seattle Genetics

Gilead

None

None

4/27/2015

Erin Reid, MD

Bristol-Myers Squibb Company;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Abbvie Pharmaceuticals;
AIDS Malignancy Consortium;
CALGB/CTSU;
Isis;
Pharmacyclics;
Takeda Pharmaceuticals North America, Inc.

None

None

None

None

10/24/2014

Ayman A. Saad, MD

None

ICARE;
IMS Consulting Group

None

None

None

4/24/2015

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Spectrum

Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.

None

None

12/15/2014

Hema Sundar, PhD

None

None

None

None

None

2/18/2015

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

None

10/10/2014

Sarika Trikha, PharmD

None

None

None

None

None

4/13/2015

Julie M. Vose, MD, MBA

Bristol-Myers Squibb Company;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.;
Incyte;
US Biotest;
US Biotest, Inc.;
Pharmacyclics;
sanofi-aventis U.S.

None

None

None

None

12/15/2014

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

10/8/2014

Joachim Yahalom, MD

None

None

None

None

None

3/24/2015

Nadeem Zafar, MD

None

None

None

None

None

1/7/2015

Andrew D. Zelenetz, MD, PhD

Abbott Laboratories;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Constellation Pharmaceuticals;
Curis;
Gilead;
Infinity;
Seattle Genetics

Amgen Inc.;
Celgene Corporation;
Genentech, Inc.;
Adaptive Biotechnology;
Alissa Pharma;
Gilead;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None

1/26/2015